Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Ord Shs BIOAF


Primary Symbol: V.BTI.H

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by TheTruth1234on May 24, 2024 7:32pm
90 Views
Post# 36056814

RE:RE:RE:RE:RE:RE:RE:JD still playing connect the dots

RE:RE:RE:RE:RE:RE:RE:JD still playing connect the dots
InitiumMMXXIII wrote: Nah, you don't know any more than the rest of us, zw. xB3 has been PUBLICLY shown to work in scientific papers by Astrazeneca (MedImmune), Texas Tech and in work by the NRC, UBC, and others.

xB3 has never been publicly described as a failure except by stock forum trolls. There is no empirical evidence, shown or referenced, that supports an opinion or conclusion of failure.

I think it's possible that xB3 has failed, but I think it's more likely that Bioasis has failed through  management incompetence, neglect, or perhaps even malice.

If you can produce evidence of failure, then do it. Otherwise you're just another anonymous bullboard poster whose opinion, without real evidence,  does not offer much in the way of credibility.

jd


"xB3 has been PUBLICLY shown to work in scientific papers by Astrazeneca (MedImmune), Texas Tech and in work by the NRC, UBC, and others"


In MICE johnny boy, in bloody MICE!!


The reason it wasnt tested in humans is because they knew it didn't work (or knew there was a high likelihood it would FAIL in humans)

The exact reason why all the Pharmaceutical companies passed on Bioasis!!

All those Drs and Scientists just couldnt connect the dots like you, Johnny boy!

The Drs couldn't read through the lines like you could!!

LMFAO 



Such an embarrassment!!


Hows bankruptcy these days Johnny boy?




<< Previous
Bullboard Posts
Next >>